Sarepta Therapeutics | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 822.38M 57.14M 2025-06
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 7.43B 1.22B 2025-06
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Daiichi Sankyo JPY 1.58T 44.86B 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Insmed USD 1.25B 1.15B 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Moderna USD 9.4B 667M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
PTC Therapeutics USD -206546000 20.79M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06


Sarepta Therapeutics Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.